Impact of Short‐Chain Fatty Acids on Glucose, Fatty Acid and Leucine Metabolism in Primary Human Myotubes
Endocrinology, Diabetes & Metabolism · 2025
DOI: 10.1002/edm2.70042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, Diabetes & Metabolism, 2025. Verfasst von Ragna Husby Tingstad und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences and Health, Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway. Hauptthemen laut MEDLINE: Muscle Fibers, Skeletal, Leucine, Glucose, Fatty Acids, Volatile. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: storbyuniversitetet.
Abstract (Originalsprache)
Introduction
Short‐chain fatty acids (SCFAs) are small molecule metabolites mainly produced during microbial fermentation of dietary fibre in the gut and have been shown to have a beneficial impact on human health. The aim of this study was to evaluate the effect of SCFAs on human skeletal muscle energy metabolism.
Methods
Primary human myotubes were analysed for glucose and fatty acid (oleic acid) metabolism, as well as insulin sensitivity and protein synthesis in the presence or absence of SCFAs.
Results
The most pronounced effects of SCFAs were observed on 14 C‐oleic acid uptake and oxidation, as well as 14 C‐leucine uptake and protein synthesis, following butyrate treatment. Butyrate increased 14 C‐leucine accumulation twofold, potentially due to protein incorporation. On the other hand, the conversion of 14 C‐leucine into free fatty acids was reduced by more than 50% by butyrate. Both 14 C‐acetate and 14 C‐butyrate were shown to be taken up and utilised by primary human myotubes. None of the SCFAs were found to influence glucose metabolism or insulin effects.
Conclusion
The results from the current study thus suggest that among the SCFAs, butyrate emerges as the most powerful SCFA in regulating primary human myotube metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences and Health, Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway.
- Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway.
- Department of Nursing and Health Promotion, Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway.
- Department of Medical Biochemistry, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
ORCID-Profile: Ragna Husby Tingstad, Christine Skagen
Förderung
- storbyuniversitetet
Zitieren
APA
Tingstad, R. H., Witczak, O., Beajani, S., Seo, S. H., Løvsletten, N. G., Skagen, C., Myhrstad, M. C. W., Telle-Hansen, V. H., Eide, L., Rustan, A. C., & Aas, V. (2025). Impact of Short‐Chain Fatty Acids on Glucose, Fatty Acid and Leucine Metabolism in Primary Human Myotubes. Endocrinology, Diabetes & Metabolism. https://doi.org/10.1002/edm2.70042
Vancouver
Tingstad RH, Witczak O, Beajani S, Seo SH, Løvsletten NG, Skagen C, et al. Impact of Short‐Chain Fatty Acids on Glucose, Fatty Acid and Leucine Metabolism in Primary Human Myotubes. Endocrinology, Diabetes & Metabolism. 2025. doi:10.1002/edm2.70042
BibTeX
@article{Tingstad2025,
author = {Tingstad, Ragna Husby and Witczak, Oliwia and Beajani, Siver and Seo, Seung Hee and Løvsletten, Nils Gunnar and Skagen, Christine and Myhrstad, Mari Charlotte Wik and Telle-Hansen, Vibeke Helen and Eide, Lars and Rustan, Arild Christian and Aas, Vigdis},
title = {Impact of Short‐Chain Fatty Acids on Glucose, Fatty Acid and Leucine Metabolism in Primary Human Myotubes},
journal = {Endocrinology, Diabetes & Metabolism},
year = {2025},
doi = {10.1002/edm2.70042}
}
EUVIMED